RECOVERY Trial: The REGN-COV Antibody Cocktail in COVID19
June 24, 2021
Background: Antibodies targeted at the SARS-CoV2 spike protein are an essential part of the body’s immune response to COVID19 infection. Infection with SARS-CoV2 stimulates the...
Marco Torres
No Evidence that REGN-COV2 (Regeneron) Antibody Cocktail Has Clinical Benefits
January 2, 2021
Background: Antibodies targeted at the SARS-CoV2 spike protein are an essential part of the body’s immune response to COVID19 infection. The recent emergency use authorization...